Vous êtes sur la page 1sur 3

7PHA1027 TRAVEL HEALTH (OPTIONAL MODULE) Semester A 2013-14

TRAVELLING WITH CHRONIC CONDITIONS PBL assessment (worth 10% of the total marks for the module) Chronic conditions to be researched: CARDIOVASCULAR DISEASE e.g. ischemic heart disease, heart failure, (include those on warfarin) DIABETES type 1 and type 2 EPILEPSY GASTROINTESTINAL CONDITIONS e.g. crohns disease, GORD PAIN CONDITIONS -MODERATE/SEVERE e.g. osteoarthritis, cancer pain RESPIRATORY CONDITIONS e.g. asthma, chronic obstructive pulmonary disease

Module learning outcomes assessed: Critically review from a scientific and practice perspective identified risks of travel. Critically evaluate current evidence-based information in relation to travel. Evaluate the role of the pharmacist and pharmaceutical scientist in travel health. Demonstrate the ability to synthesise and communicate travel health plans for diverse types of traveller and types of travel. Recommend, employ and advise on the storage and formulation of pharmaceutical products.

STUDENT INSTRUCTIONS PBL group work (usual rules apply) each group allocated a condition Find out additional information that travellers will need when travelling with the chronic condition. Assume that the traveller will already have been provided with standard travel advice.

Task 1 - Design an A4 size patient information leaflet (PIL) The leaflet can be printed on both sides of the A4 sheet and can be designed to be folded. Have a look at some PILs displayed in pharmacies and you can use this website and its references for guidance and further information on design and use of language http://fms-

itskills.ncl.ac.uk/howto/infoleaflet.html
Task 2 Prepare a 15 minute group presentation; be prepared to answer questions; be prepared to assess your audiences learning. Imagine that you are running a lunch-time training session for colleagues who run a travel clinic. You are providing them with the information they need to advise on your allocated chronic condition. (The imaginary colleagues will be the other Travel Health students.) Decide on key learning points and ensure that your audience have understood and learnt these points as part of your presentation.

7PHA1027 TRAVEL HEALTH (OPTIONAL MODULE) Semester A 2013-14

THEMES

Below are the main areas that should be covered using the allocated headings Include all aspects of medical preparation, choice of destination and appropriate signposting Disease management during the flight (incl. medicines and medical devices); the risks of flying; appropriate advice Include appropriate cautions for other methods of travel (e.g. road, rail, sea, foot); type of travel (including mass gatherings); disease management; pharmaceutical considerations; legislation for drugs of destination countries

Preparation before travel

The flight

The destination/s

Assessment Guidance and Deadlines As a group you will brainstorm this case in order to identify any issues surrounding the patient travelling with his/her chronic condition. You will then develop the case as a group outside of the brainstorm session. You can have the opportunity to discuss your progress and any problems with members of the academic staff by using StudyNet or by arranging a meeting. 1. You will be allocated to your PBL group and chronic condition 2. There will be a timetabled session to brainstorm case and establish key questions 3. Divide the questions you produce and allocate them. Identify the list of resources you will explore in order to answer the case questions. 4. Post summary of key questions and answers on PBL StudyNet site by 8am Monday 14th October. 5. Tutor will review and feedback. 6. Submit a draft patient information leaflet and oral presentation on your PBL StudyNet site by 8am Tuesday 26th November. N.B. Students missing this deadline WILL NOT get any feedback. 7. Submit your final A4 patient information leaflet on your PBL group StudyNet site by 8am Monday 2 December. 8. Agree which team members will deliver the oral case presentation and which students will take questions in the final session. 9. On the day of the oral presentation hand the group moderation form to module lead and submit the final presentation slides and test of your audiences learning on your PBL StudyNet site. 10. PBL group oral presentations will be held on Monday 3rd December 9:00am (subject to central timetable changes)

7PHA1027 TRAVEL HEALTH (OPTIONAL MODULE) Semester A 2013-14

N.B. The module exam may include questions on any aspect of all five cases.

Marks The Travelling with Chronic Conditions case is worth 10% of the module marks. This is further broken down into 60% for the group presentation and 40% for the A4 patient information leaflet. Please refer to the Travelling with Chronic Conditions marking criteria documents for detailed breakdown of marks. The group will also be asked to complete a peer assessment to comment on the effort put in by each team member. Contribution to the group work is compulsory. Any student that only partially contributes will receive a capped mark of 50% for this assessment. Any student that does not contribute at all will receive 0% for this assessment. The presentation is compulsory. Anyone missing the presentation will be allocated a 1000 word essay to complete.

Further reference sources: Remember to look at www.bnf.org BNF (66) as a starting point. In addition to the recommended module references, you might like to refer to: British Pharmacopoeia Summary of Product Characteristics www.emc.medicines.org.uk Foreign & Commonwealth Office https://www.gov.uk/browse/abroad/travel-abroad Diabetes UK www.diabetes.org.uk

Epilepsy Action www.epilepsy.org.uk The Royal Associates for Disability and Rehabilitation (RADAR)
http://www.nidirect.gov.uk/index/information-and-services/people-with-disabilities/travelholidays-and-breaks.htm

British Thoracic Society www.brit-thoracic.org.uk http://www.britthoracic.org.uk/Guidelines/Air-Travel-Guideline.aspx

British Heart Foundation www.bhf.org.uk Home Office Controlled Drugs Personal License
http://webarchive.nationalarchives.gov.uk/20130128103514/http://www.homeoffice.gov.u k/drugs/licensing/personal/?view=Standard

Crohns and Colitis UK fact sheet http://www.crohnsandcolitis.org.uk/

Vous aimerez peut-être aussi